Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canal-S
- Development stage
- Unknown
- Lead developer
- GC Biopharma
- Modality
- Small Molecules
- Administration
- Intracanal
01
Overview
Canal-S is a dental medical device used as a root canal filling material (sealer) in endodontic procedures. Developed and marketed by GC Showa Yakuhin, it is typically used in conjunction with gutta-percha points to provide a permanent seal for the root canal system after cleaning and shaping. The product functions as a zinc oxide-guaiacol based sealer, providing antimicrobial properties and ensuring a fluid-tight seal to prevent reinfection of the periapical tissues. It is a long-standing product in the Japanese dental market, classified as a dental material for permanent obturation.
- Brand names
- Canal-S
- Other names
- Canal-S (endodontic product)キャナール-S
02
Targets
GYS1 (Glycogen synthase 1)GYS2 (Glycogen synthase 2)SDH (Mitochondrial electron transport chain complex II)
Beyond the preview
Go deeper on Canal-S.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canal-S.